Your browser doesn't support javascript.
loading
Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome-Single Centre Observational Study in the United Kingdom.
Noble, Hithin; Crossette-Thambiah, Christina; Odho, Zain; Karawitage, Nilanthi; Logan, Karen; Pericleous, Charis; Laffan, Mike; Arachchillage, Deepa R J.
Affiliation
  • Noble H; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.
  • Crossette-Thambiah C; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.
  • Odho Z; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Karawitage N; Department of Laboratory medicine, Royal Brompton Hospital, London, United Kingdom.
  • Logan K; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.
  • Pericleous C; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.
  • Laffan M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Arachchillage DRJ; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.
Semin Thromb Hemost ; 49(5): 553-557, 2023 07.
Article de En | MEDLINE | ID: mdl-36318961

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome des anticorps antiphospholipides Type d'étude: Observational_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Semin Thromb Hemost Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome des anticorps antiphospholipides Type d'étude: Observational_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Semin Thromb Hemost Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni